CTG Pharma ^{For Profit}

CTG Pharma has developed an innovative solution that will allow CAR T therapy for HER 2 positive solid tumors while mitigating toxicity and on-target off-tumor reactions. CTG Pharma has the best possible solutions, with a Library of 65K promoters, Safer CAR T for the treatment of solid tumors, applicable to any CAR, and Suitable for a variety of tumor micro-environment conditions